Alto Neuroscience develops drug candidates for psychiatric disorders, using biomarkers found through data analytics to select patients. It last closed at $24.93 on Nov 17, down 8.14% on the day.
Only 1 firm rated ANRO in the past 90 days, not enough for a consensus
Average 12-month target
$60.00
▲ 140.7% upside
Based on 1 analyst who set a price target on ANRO in the past 90 days. The average target is $60.00, with a high of $60.00 and a low of $60.00, compared with the last close of $24.93.
Low $60.00Avg $60.00High $60.00
Blue marker: last close $24.93
Highest target$60.00
Average target$60.00
Lowest target$60.00
Latest rating changes
HC Wainwright & Co.Target raised
Oct 19Buy$55 → $60
HC Wainwright & Co.Maintained
Aug 17Buy$55
WedbushMaintained
Aug 13Hold$26
BTIGMaintained
Aug 13Buy$37
BairdMaintained
May 18Buy$36
Date
Firm
Action
Rating
Price target
Oct 19
HC Wainwright & Co.
Target raised
Buy
$55 → $60
Aug 17
HC Wainwright & Co.
Maintained
Buy
$55
Aug 13
Wedbush
Maintained
Hold
$26
Aug 13
BTIG
Maintained
Buy
$37
May 18
Baird
Maintained
Buy
$36
Loading…
Technical Analysis
ANRO · as of the Nov 17 close · updated after every close
Uptrend
The stock sits between its 20 and 50 day averages. It is sitting right on its 200 day average, a level many traders watch. Momentum is improving (RSI 47). The nearest support is the 20 day average at $24.85, and the nearest resistance the swing high (Oct 21) at $25.01.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityNormal, 8.2%/day
Key levels
$37.4852 week high+50.3%
$28.03100 day average+12.4%
$26.43Pivot R1+6.0%
$25.9850 day average+4.2%
$25.61Pivot+2.7%
$25.01Swing high (Oct 21)+0.3%
$24.93Last close
$24.8520 day average−0.3%
$24.84200 day average−0.4%
$24.30Swing low (Jul 7)−2.5%
$24.11Pivot S1−3.3%
$12.5152 week low−49.8%
Indicators
RSI (14)
47.34
Middle of its range
Neutral
MACD
0.81
Above its signal line
Bullish
Stochastic
48.5
Middle of its range
Neutral
ADX (14)
28.0
Trending up
Williams %R
-71.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
18.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+9.9%
Change over 10 sessions
Bullish
ATR (14)
$2.05
Typical daily range, 8.2% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 16.3%/day
Key levels
$37.4852 week high+50.3%
$28.03100 day average+12.4%
$26.43Pivot R1+6.0%
$25.9850 day average+4.2%
$25.61Pivot+2.7%
$25.01Swing high (Oct 21)+0.3%
$24.93Last close
$24.8520 day average−0.3%
$24.84200 day average−0.4%
$24.30Swing low (Jul 7)−2.5%
$24.11Pivot S1−3.3%
$12.5152 week low−49.8%
Indicators
RSI (14)
48.82
Middle of its range
Neutral
MACD
0.45
Below its signal line
Bearish
Stochastic
32.6
Middle of its range
Neutral
ADX (14)
31.8
Trending up
Williams %R
-77.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-34.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−22.1%
Change over 10 sessions
Bearish
ATR (14)
$4.07
Typical daily range, 16.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for ANRO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ANRO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in ANRO in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANRO is in one of them and how their past ANRO trades turned out.
Alto Neuroscience is a pharmaceutical company based in Mountain View, California, that develops drugs for psychiatric disorders. It uses data analytics and machine learning to find biomarkers that can help identify which patients are most likely to benefit from a given treatment. The company is developing its product candidates for conditions including major depressive disorder and schizophrenia, and it has not yet commercialized a drug. Its work is aimed at patients with these conditions and the clinicians who treat them.